Solventum Corporation (BMV:SOLV)

Market Cap	235.85B
Revenue (ttm)	158.18B
Net Income (ttm)	7.17B
Shares Out	n/a
EPS (ttm)	41.19
PE Ratio	32.91
Forward PE	12.24
Dividend	n/a
Ex-Dividend Date	n/a

Volume	128
Average Volume	57
Open	1,350.06
Previous Close	n/a
Day's Range	1,350.06 - 1,350.06
52-Week Range	1,075.00 - 1,700.00
Beta	n/a
RSI	50.81
Earnings Date	Aug 7, 2025

About Accolade

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates in four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment offers solutions for negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wr...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 2023
• Employees: 22,000
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: SOLV

Financial Performance

In 2024, Solventum's revenue was $8.25 billion, an increase of 0.70% compared to the previous year's $8.20 billion. Earnings were $479.00 million, a decrease of -64.41%.